The global alpha mannosidosis market size was valued at USD 9.92 billion in 2021 and is poised to grow at a significant CAGR of 17.8% during the forecast period 2022–2028. The market exclusivity granted to items with the orphan medication designation for several years is pharmaceutical corporations' most significant financial incentive. Since, during this time, regulatory bodies cannot...
The global alpha mannosidosis market size was valued at USD 9.92 billion in 2022 and is poised to grow at a significant CAGR of 17.8% during the forecast period 2023-29. It also includes market size and projection estimations for each of the five major regions from 2023 to 2029. The research report includes historical data, trending features, and market growth estimates for the future....
The report "Alpha Mannosidosis Market by Treatment Type (Bone Marrow Transplant, and Enzyme Replacement Therapy), by Indication, (Type I, Type II, and Type III), by End User (Hospitals, and Specialty Clinics), - Global Forecasts to 2030"
The global Alpha Mannosidosis Market is projected to reach USD 10.2 billion in 2023, registering at a Compound Annual Growth Rate (CAGR) of 18.8% during...
The global alpha mannosidosis market is valued at USD billion in 2021 and is poised to grow at a significant CAGR of 17.8% over 2022–2028. Alpha-mannosidosis is a rare inherited genetic disorder that affects the organs and tissues of the individual who has it. The treatment relies on recognising as well as preventing polysaccharide accumulations inside mutant cells, which...
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Romaian